Achieving Excellence in Tender and Deal Management

The public tendering process accounts for 70-85% of global revenue for medical technology providers and 25-40% for pharma companies. Whoever can best respond to tenders, as well as the individually negotiated deals used by private companies, will maxim…

Inside the Market of Emerging Biotechs

For nearly a decade, biotech companies and their venture backers enjoyed a historic boom. Although momentum has come to a halt, many of the largest venture investors remain flush with cash, while progress in gene editing, messenger RNA and cell therapi…